Skip to main navigation Skip to search Skip to main content

Phase Ib study of wnt inhibitor ipafricept with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer

  • Efrat Dotan
  • , Dana B. Cardin
  • , Heinz Josef Lenz
  • , Wells Messersmith
  • , Bert O'Neil
  • , Steven J. Cohen
  • , Crystal S. Denlinger
  • , Safi Shahda
  • , Igor Astsaturov
  • , Ann M. Kapoun
  • , Rainer K. Brachmann
  • , Shailaja Uttamsingh
  • , Robert J. Stagg
  • , Colin Weekes
  • Vanderbilt University
  • University of Southern California
  • University of Colorado Anschutz Medical Campus
  • Indiana University-Purdue University Indianapolis
  • Thomas Jefferson University
  • Fox Chase Cancer Center
  • OncoMed Pharmaceuticals
  • Massachusetts General Hospital

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Phase Ib study of wnt inhibitor ipafricept with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science